Patents by Inventor Daniela ROVERSI

Daniela ROVERSI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRF2 receptor agonists and their use in therapy
    Patent number: 12679878
    Abstract: The present disclosure provides compounds which are peptides comprising the amino acid sequence of the formula (I) disclosed herein or pharmaceutically acceptable salts thereof. The compounds act as agonists of the corticotropin-releasing factor receptor 2 (CRF2) and are useful in therapy, especially in the treatment or prevention of cardiovascular diseases, obesity and diabetes.
    Type: Grant
    Filed: August 18, 2021
    Date of Patent: July 14, 2026
    Assignee: SANOFI
    Inventors: Stephane Illiano, Laurence Lucats, Laetitia Ledein, Philippe Beauverger, Philip Janiak, Marie-Laure Ozoux, Nis Halland, Ziyu Li, Ralf Elvert, Andreas Evers, Elisabetta Bianchi, Alessia Santorprete, Daniela Roversi, Martina Tripepi
  • CRF2 RECEPTOR AGONISTS AND THEIR USE IN THERAPY
    Publication number: 20260001928
    Abstract: The present disclosure provides compounds which are peptides comprising the amino acid sequence of the formula (I) disclosed herein or pharmaceutically acceptable salts thereof. The compounds act as agonists of the corticotropin-releasing factor receptor 2 (CRF2) and are useful in therapy, especially in the treatment or prevention of cardiovascular diseases, kidney disease, obesity, diabetes, sarcopenia, particularly obesity-linked sarcopenia, heart failure, cachexia, and pulmonary hypertension.
    Type: Application
    Filed: February 21, 2023
    Publication date: January 1, 2026
    Inventors: Philip JANIAK, Marie-Laure OZOUX, Daniela ROVERSI, Elisabetta BIANCHI, Martina TRIPEPI, Alessia SANTOPRETE
  • CRF2 RECEPTOR AGONISTS AND THEIR USE IN THERAPY
    Publication number: 20250243255
    Abstract: The present disclosure provides compounds which are peptides comprising the amino acid sequence of the formula (I) disclosed herein or pharmaceutically acceptable salts thereof. The compounds act as agonists of the corticotropin-releasing factor receptor 2 (CRF2) and are useful in therapy, especially in the treatment or prevention of cardiovascular diseases, obesity and diabetes.
    Type: Application
    Filed: August 18, 2021
    Publication date: July 31, 2025
    Inventors: Stephane ILLIANO, Laurence LUCATS, Laetitia LEDEIN, Philippe BEAUVERGER, Philip JANIAK, Marie-Laure OZOUX, Nis HALLAND, Ziyu LI, Ralf ELVERT, Andreas EVERS, Elisabetta BIANCHI, Alessia SANTORPRETE, Daniela ROVERSI, Martina TRIPEPI